Nutraceutical Therapy for Patients Suffering from Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME or CFS), Post-Covid Syndrome (PCoS), or Alzheimer Disease (AD)

Comhaire F*; Pen J; Deslypere JP

doi:10.47739/2379-9501/1032

Nutraceutical Therapy for Patients Suffering from Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME or CFS), Post-Covid Syndrome (PCoS), or Alzheimer Disease (AD)

Short Communication | Open Access Volume 6 | Issue 1 |

Article DOI : https://doi.org/10.47739/2379-9501/1032

Comhaire F*¹ Pen J² Deslypere JP¹

^1. Consulting Specialist for Internal Medicine, Endocrinology and Metabolic Diseases, Fertility-Belgium Clinic, Belgium
^2. Specialist Internal Medicine and Ultrasonography, Belgium

+ Show More - Show Less

Corresponding Authors

Frank Comhaire, Consulting Specialist for Internal Medicine, Endocrinology and Metabolic Diseases, Fertility-Belgium Clinic, Weststraat, 16, 9880 Aalter, Belgium, Tel: 32 475618555; Email: frank.comhaire@telenet.be

Annals of Neurodegenerative Disorders

Annals of Neurodegenerative Disorders

Annals of Neurodegenerative Disorders

Nutraceutical Therapy for Patients Suffering from Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME or CFS), Post-Covid Syndrome (PCoS), or Alzheimer Disease (AD)

Journals

JSciMed

Journals

Nutraceutical Therapy for Patients Suffering from Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME or CFS), Post-Covid Syndrome (PCoS), or Alzheimer Disease (AD)

Journals

Subscribe to Newsletters